Peking University Cancer Hospital & Institute: Stomach Neoplasms trials
The registry lists 14 Stomach Neoplasms studies with Peking University Cancer Hospital & Institute as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal CancersNot yet recruitingNCT07775859
- Non-Operative Management and Following Immunotherapy for Colorectal Cancer and Other GI CancersNot yet recruitingNCT07656740
- Safety and Efficacy of NOM and OPFS Versus RO for dMMR/MSI-H or POLE-Mutated Gastrointestinal CancersNot yet recruitingNCT07642323
- Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma With Microsatellite Instability/Mismatch Repair DeficiencyNot yet recruitingNCT07595523Phase 2
- Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe.Not yet recruitingNCT06435741Not applicable
- Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric CancerRecruitingNCT06306755Not applicable
- Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant ChemotherapyStatus unknownNCT04408859
- Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for AGCStatus unknownNCT03708783Not applicable
- Comparison Between Double Tract Anastomosis and Esophagogastrostomy After Radical Proximal GastrectomyStatus unknownNCT03613142Not applicable
- Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerCompletedNCT03425058
- Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric CancerTerminatedNCT02867839Phase 3
- Effect of Laparoscopy-Assisted Distal Gastrectomy for Locally Advanced Gastric CancerStatus unknownNCT02464215Not applicable
- DNA Methylation Biomarkers and Metastasis of Gastric CarcinomaCompletedNCT02159339
- Xeloda Plus Paclitaxel in Gastric Cancer With Liver MetastasisStatus unknownNCT01167049Phase 2